
Company valuation, historical trends, and peer comparisons.
According to InflaRx N.V.’s latest financial reports and current stock price. The company's current Enterprise Value is 113.25M. This represents a change of 40.25% compared to the average of 80.75M of the last 4 quarters.
The mean historical Enterprise Value of InflaRx N.V. over the last ten years is 203.01M. The current 113.25M Enterprise Value has changed -44.22% with respect to the historical average. Over the past ten years (40 quarters), IFRX's Enterprise Value was at its highest in in the March 2019 quarter at 816.62M. The Enterprise Value was at its lowest in in the March 2025 quarter at 13.09M.
Average
203.01M
Median
118.02M
Minimum
42.72M
Maximum
740.49M
Discovering the peaks and valleys of InflaRx N.V. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 156.43%
Maximum Annual Enterprise Value = 740.49M
Minimum Annual Increase = -91.96%
Minimum Annual Enterprise Value = 42.72M
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 42.72M | -65.26% |
| 2024 | 122.97M | 77.26% |
| 2023 | 69.37M | -38.65% |
| 2022 | 113.08M | -24.33% |
| 2021 | 149.44M | 73.82% |
| 2020 | 85.98M | 44.40% |
| 2019 | 59.54M | -91.96% |
| 2018 | 740.49M | 156.43% |
| 2017 | 288.77M | -19.29% |
| 2016 | 357.79M | 4.99% |
The current Enterprise Value of InflaRx N.V. (IFRX) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
78.35M
5-year avg
99.52M
10-year avg
203.01M
InflaRx N.V.’s Enterprise Value is less than Shattuck Labs, Inc. (456.24M), greater than Connect Biopharma Holdings Limited (22.73M), greater than ImageneBio Inc (-46223850.00), greater than Kalaris Therapeutics Inc (2.34M), greater than Artiva Biotherapeutics, Inc. (-85288694.00), less than Sutro Biopharma, Inc. (121.26M), greater than Quince Therapeutics, Inc. (-83770710.00), greater than Metagenomi, Inc. Common Stock (28.54M), greater than Context Therapeutics Inc. (-24047966.00), greater than aTyr Pharma, Inc. (10.29M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 456.24M | $516.87M | |
| 22.73M | $49.15M | |
| -46223850.00 | $46.54M | |
| 2.34M | $44.12M | |
| -85288694.00 | $206.32M | |
| 121.26M | $164.82M | |
| -83770710.00 | $8.83M | |
| 28.54M | $29.84M | |
| -24047966.00 | $18.70M | |
| 10.29M | $15.15M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like InflaRx N.V. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like InflaRx N.V. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is InflaRx N.V.'s Enterprise Value?
What is the highest Enterprise Value for InflaRx N.V. (IFRX)?
What is the 3-year average Enterprise Value for InflaRx N.V. (IFRX)?
What is the 5-year average Enterprise Value for InflaRx N.V. (IFRX)?
How does the current Enterprise Value for InflaRx N.V. (IFRX) compare to its historical average?